Australian biopharma Clinuvel to shed up to 20% of workforce in move to US

Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.— but up to a fifth of the company’s workforce won’t be staying for the trans-Pacific pivot.